Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 1738430, 6 pages
http://dx.doi.org/10.1155/2016/1738430
Research Article

The Effects of Infliximab on Laminin, NFκB, and Anti-TNF Expression through Its Effect on Ischemic Liver Tissue

1School of Medicine, Department of Gastroenterology, Recep Tayyip Erdoğan University, 53100 Rize, Turkey
2School of Medicine, Department of Embriology and Histology, Recep Tayyip Erdoğan University, 53100 Rize, Turkey
3School of Medicine, Department of Hematology, Recep Tayyip Erdoğan University, 53100 Rize, Turkey

Received 22 February 2016; Accepted 22 March 2016

Academic Editor: Paolo Gionchetti

Copyright © 2016 Remzi Adnan Akdogan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Colletti, D. G. Remick, G. D. Burtch, S. L. Kunkel, R. M. Strieter, and D. A. Campbell, “Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat,” The Journal of Clinical Investigation, vol. 85, no. 6, pp. 1936–1943, 1990. View at Publisher · View at Google Scholar
  2. N. C. Teoh, “Hepatic ischemia reperfusion injury: contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-the good, bad and deadly,” Journal of Gastroenterology and Hepatology, vol. 26, supplement 1, pp. 180–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Takahashi, R. W. Ganster, T. Ishikawa et al., “Protective role of NF-κB in liver cold ischemia/reperfusion injury: effects of IκB gene therapy,” Transplantation Proceedings, vol. 33, no. 1-2, p. 602, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kuboki, T. Okaya, R. Schuster et al., “Hepatocyte NF-κB activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 292, no. 1, pp. G201–G207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. F. Mahmoud, S. M. El Shazly, and W. Barakat, “Inhibition of TNF-α protects against hepatic ischemia–reperfusion injury in rats via NF-κB dependent pathway,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 385, no. 5, pp. 465–471, 2012. View at Publisher · View at Google Scholar
  6. A. Pergel, M. Kanter, A. F. Yucel, I. Aydin, M. Erboga, and A. Guzel, “Anti-inflammatory and antioxidant effects of infliximab in a rat model of intestinal ischemia/reperfusion injury,” Toxicology and Industrial Health, vol. 28, no. 10, pp. 923–932, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Guzel, M. Kanter, A. Guzel, A. Pergel, and M. Erboga, “Anti-inflammatory and antioxidant effects of infliximab on acute lung injury in a rat model of intestinal ischemia/reperfusion,” Journal of Molecular Histology, vol. 43, no. 3, pp. 361–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Pech, J. Fujishiro, T. Finger et al., “Perioperative infliximab application has marginal effects on ischemia-reperfusion injury in experimental small bowel transplantation in rats,” Langenbeck's Archives of Surgery, vol. 397, no. 1, pp. 131–140, 2012. View at Publisher · View at Google Scholar · View at Scopus